Suven Pharmaceuticals Ltd.
AGMAug. 18, 2022, 11:30 a.m.
Sr noTypeResolutionIiAS View
1OrdinaryAdoption of standalone and consolidated financial statements for the year ended 31 March 2022
2OrdinaryConfirm first interim dividend of Rs. 3.0 per share (face value Re. 1.0) already paid during FY22
3OrdinaryApprove and ratify second interim dividend of Rs.2.0 per share (face value Re. 1.0) for FY22
4OrdinaryReappoint Dr. Jerry Jeyasingh, (DIN: 08589727) as Non-Executive Non-Independent Director, liable to retire by rotation


Enter your details


Summary

Particulars
Meeting Report
+ GST @ 18%
Amount
₹ 6,500
₹ 1,170

Total
₹ 7,670